AXL and head and neck squamous cell carcinoma: By contrast, we found AXL to be the predominantly expressed TAM receptor in our SCC-1 and SCC-25 cells (Figure 5A), as was also reported for additional OSCC cell lines [4], HNSCC cell lines and tumors [5].